🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Formoterol

Found 601 matching trials

Non-inferiority Evaluation of Trimbow in Critically Ill Patients Admitted in ICU Compared to Standard of Care

PHASE4

Objective: To evaluate non-inferiority of Trimbow, an approved therapy for ...

Status

Unknown

Location

Multiple Locations

Start Date

2021-02-15

Trial ID

NCT04737655

Treatments Being Tested

TRIMBOW® pressurised inhalation solution: Beclometasone dipropionate / formoterol fumarate /glycopyrronium 87/5/9 µg per inhalation

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

PHASE3

The purpose of this study is to compare the efficacy and safety of the fixe...

Status

Completed

Location

Research Center

Start Date

2006-06

Trial ID

NCT00393952

Treatments Being Tested

Fluticasone propionate/Formoterol fumarate 250/10 Placebo Fluticasone propionate/Formoterol fumarate 100/10 Fluticasone propionate 250 Formoterol fumarate 10

Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.

N/A

The objective of the study is to evaluate the effect of frequency of use wi...

Status

Withdrawn

Location

Multiple Locations

Start Date

2016-07

Trial ID

NCT02811315

Treatments Being Tested

Observational. Non interventional study

A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

PHASE1

The primary objective was: \- to assess the bioequivalence of a single dos...

Status

Completed

Location

Quotient Clinical Ltd

Start Date

2014-09

Trial ID

NCT02237508

Treatments Being Tested

Z7200 without oral activated charcoal Symbicort Turbohaler without oral activated charcoal Z7200 with oral activated charcoal Symbicort Turbohaler with oral activated charcoal

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

PHASE4

This Phase IV study is an a multi-centre, randomised open label, two way cr...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-11-14

Trial ID

NCT02233803

Treatments Being Tested

NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler NEUMOTEX 400 (Budesonide 400 mcg)Salbutamol 100 mcg pMDI

Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

PHASE1

The purpose of this study is to compare the test product Budesonide/formote...

Status

Completed

Location

Orion Pharma Phase I Unit

Start Date

2011-07

Trial ID

NCT01386996

Treatments Being Tested

Budesonide/formoterol Easyhaler 320/9 microg Symbicort Turbuhaler forte

EXACERBATIONS AND REAL-WORLD OUTOMES AMONG PATIENTS WITH COPD INITIATING BREZTRI (EROS+CP Japan Study)

N/A

A retrospective real-world data study, assessing the relationship between t...

Status

Completed

Location

AstraZeneca

Start Date

2024-08-15

Trial ID

NCT07103642

Treatments Being Tested

BGF

A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer

PHASE1

The primary purpose of this study is to demonstrate the equivalence of bude...

Status

Withdrawn

Location

Multiple Locations

Start Date

2024-10-17

Trial ID

NCT06340581

Treatments Being Tested

Treatment A: BGF MDI HFA Treatment B: BGF MDI HFO Treatment C: BGF MDI HFO AeroChamber Plus Flow-Vu Spacer

A Multicenter, Randomized, Parallel, Two-period, Non-inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

PHASE3

A phase III study, multicenter, randomized, parallel, open, two-period, com...

Status

Completed

Location

Eurofarma Laboratorios S.A

Start Date

2023-04-19

Trial ID

NCT04233190

Treatments Being Tested

Alenia® 12mcg + 400mcg / Alenia® 6mcg + 200mcg

Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing

PHASE4

The study compares Buventol® Easyhaler® and Bufomix® Easyhaler® to the curr...

Status

Completed

Location

Helsinki University Hospital

Start Date

2021-11-11

Trial ID

NCT05084222

Treatments Being Tested

Buventol® Easyhaler® 200 µg/inhalation dmDPI Bufomix® Easyhaler® 160/4.5 µg/inhalation dmDPI Ventoline® Evohaler® 100 µg/inhalation pMDI

Previous Next